Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Novartis on schedule for 2001 launch of Zelmac

Aug. 17, 2000

Viragen to file IND for Omniferon, enroll additional patients in HCV trial

Aug. 17, 2000

Tachykinin antagonists discovered at Nippon Zoki

Aug. 11, 2000

Maxim and Roche to develop combination therapy for hepatitis C and cancer

Aug. 11, 2000

Gene for gastroesophageal reflux disease mapped

Aug. 10, 2000

Study commences to evaluate long-term benefit of chronic hepatitis C treatment

Aug. 10, 2000

Zadaxin receives expanded marketing approval in Argentina

Aug. 10, 2000

Forest licenses dexloxiglumide from Rotta for treatment of IBS

Aug. 8, 2000

SciClone begins marketing and distribution of Zadaxin in Mexico

Aug. 7, 2000

Mitsubishi Chemical patents amide derivatives active against H. pylori

Aug. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....